Interact to see
Advertisement
Advertisement
MEDGX vs REBAX
MEDGX vs REBAX Comparison
Open Charts MEDGX vs REBAX
MFS Emerging Markets Debt R4
Price$12.54
Change-$0.01 (-0.08%)
VolumeN/A
Net Assets7.55B
Columbia Emerging Markets Bond A
Price$9.98
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets341.82M
MEDGX vs REBAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
MEDGX vs. REBAX commentary
Oct 07, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MEDGX is a Hold and REBAX is a Hold.
FUNDAMENTALS
Fundamentals
MEDGX has more cash in the bank: 7.55B vs. REBAX (342M). MEDGX pays higher dividends than REBAX: MEDGX (5.50) vs REBAX (4.91). MEDGX was incepted earlier than REBAX: MEDGX (17 years) vs REBAX (20 years). REBAX (1.13) is less costly to investors than MEDGX (0.82). MEDGX is a more actively managed with annual turnover of: 58.00 vs. REBAX (41.00). MEDGX has a lower initial minimum investment than REBAX: MEDGX (0) vs REBAX (2000). REBAX (7.90) and MEDGX (7.82) have marching annual gain over last year. MEDGX return over 5 years is better than : 13.84 vs. REBAX (11.08).
| MEDGX | REBAX | MEDGX / REBAX | |
| Total Expense Ratio | 0.81 | 1.13 | 72% |
| Annual Report Gross Expense Ratio | 0.82 | 1.13 | 73% |
| Fund Existence | 17 years | 20 years | - |
| Gain YTD | 9.196 | 9.571 | 96% |
| Front Load | N/A | 5% | - |
| Min. Initial Investment | 0 | 2000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 7.55B | 342M | 2,208% |
| Annual Yield % from dividends | 5.50 | 4.91 | 112% |
| Returns for 1 year | 7.82 | 7.90 | 99% |
| Returns for 3 years | 40.07 | 38.04 | 105% |
| Returns for 5 years | 13.84 | 11.08 | 125% |
| Returns for 10 years | 49.12 | 44.25 | 111% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement